FDA approves new COVID vaccines
Digest more
In August 2026, Pfizer and BioNTech received U.S. FDA approval for their updated COMIRNATY COVID-19 vaccine targeting the XFG ...
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.
Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than those who received the Moderna shot, a new study of 1.47 million people found.
Everything you need to know about the COVID vaccine, when you'll get it, how much it will cost and what it means.
Rep. Thomas Massie (R-Ky.) questioned Vice President JD Vance‘s silence after the Trump administration established billions for Pfizer Inc.‘s COVID-19 vaccine contracts for 2026 and 2027. On Sunday, ...
Patent expirations are forcing Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) to prove that their newer medicines ...
Preinfection COVID-19 vaccination lowers the risk for persistent post-COVID-19 conditions in children and adolescents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results